|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/498 | |
| A61P 27/02 |
| (11) | Patento numeris | 1758552 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05741206.6 |
| Europos patento paraiškos padavimo data | 2005-04-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-03-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-07-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/014607 |
| Data | 2005-04-26 |
| (87) | Numeris | WO 2005/110368 |
| Data | 2005-11-24 |
| (30) | Numeris | Data | Šalis |
| 836911 | 2004-04-30 | US |
| (72) |
BURKE, James, US
HUGHES, Patrick, M., US
ZHANG, Kai-Ming, US
LIN, Ton, US
HUANG, Glenn, US
JACKSON, Brittany, A., US
WHEELER, Larry, A., US
DONN, Rosy, S., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | INTRAOCULAR IMPLANTS OF ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR PREVENTING OR REDUCING OCULAR VASCULAR OCCLUSIONS |
| INTRAOCULAR IMPLANTS OF ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR PREVENTING OR REDUCING OCULAR VASCULAR OCCLUSIONS |